Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia
- PMID: 30808768
- PMCID: PMC6397565
- DOI: 10.1073/pnas.1810572116
Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia
Abstract
Natural systems, including the brain, often seem chaotic, since they are typically driven by complex nonlinear dynamical processes. Disruption in the fluid coordination of multiple brain regions contributes to impairments in information processing and the constellation of symptoms observed in neuropsychiatric disorders. Schizophrenia (SZ), one of the most debilitating mental illnesses, is thought to arise, in part, from such a network dysfunction, leading to impaired auditory information processing as well as cognitive and psychosocial deficits. Current approaches to neurophysiologic biomarker analyses predominantly rely on linear methods and may, therefore, fail to capture the wealth of information contained in whole EEG signals, including nonlinear dynamics. In this study, delay differential analysis (DDA), a nonlinear method based on embedding theory from theoretical physics, was applied to EEG recordings from 877 SZ patients and 753 nonpsychiatric comparison subjects (NCSs) who underwent mismatch negativity (MMN) testing via their participation in the Consortium on the Genetics of Schizophrenia (COGS-2) study. DDA revealed significant nonlinear dynamical architecture related to auditory information processing in both groups. Importantly, significant DDA changes preceded those observed with traditional linear methods. Marked abnormalities in both linear and nonlinear features were detected in SZ patients. These results illustrate the benefits of nonlinear analysis of brain signals and underscore the need for future studies to investigate the relationship between DDA features and pathophysiology of information processing.
Keywords: EEG; delay differential analysis; mismatch negativity; nonlinear dynamics; schizophrenia.
Conflict of interest statement
Conflict of interest statement: G.A.L. has served as a consultant to Astellas, Boehringer-Ingelheim, Dart Neuroscience, Heptares, Lundbeck, Merck, NASA, NeuroSig, and Takeda. The other authors report no biomedical financial interests or potential conflicts of interests.
Figures





References
Publication types
MeSH terms
Grants and funding
- K23 MH102420/MH/NIMH NIH HHS/United States
- R01 MH042228/MH/NIMH NIH HHS/United States
- R01 MH065571/MH/NIMH NIH HHS/United States
- T32 MH020002/MH/NIMH NIH HHS/United States
- R01 MH065558/MH/NIMH NIH HHS/United States
- R01 MH094320/MH/NIMH NIH HHS/United States
- F30 MH115605/MH/NIMH NIH HHS/United States
- R01 EB026899/EB/NIBIB NIH HHS/United States
- R01 MH059803/MH/NIMH NIH HHS/United States
- UL1 TR001102/TR/NCATS NIH HHS/United States
- R01 MH065707/MH/NIMH NIH HHS/United States
- T32 GM007198/GM/NIGMS NIH HHS/United States
- R01 MH065554/MH/NIMH NIH HHS/United States
- R01 MH065578/MH/NIMH NIH HHS/United States